<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="any special cure. However, some others need special and emergency" exact="treatment" post="to get rid of this widespread disease. Till now,"/>
 <result pre="researchers to develop faster and more reliable methods for earlier" exact="treatment" post="of patients and rescue more people. Graphical abstract Keywords"/>
 <result pre="species, including humans [4]. The virus that causes the COVID-19" exact="infection" post="belongs to the Î² coronaviruses family. Since the beginning"/>
 <result pre="conduct virus surveillance. The disease is typically confirmed by reverse-transcription" exact="polymerase chain reaction" post="(RT-PCR) reverse Real-Time PCR assay (rRT-PCR), which can be"/>
 <result pre="the sensitivity of RT-PCR might not be enough for the" exact="diagnosis" post="of the disease. So the Computed tomography (CT), as"/>
 <result pre="newly developed or in developing medicines or remedies for the" exact="treatment" post="of COVID-19 disease to help researchers around the world"/>
 <result pre="[12]. SARS-CoV-2 is a virus from coronaviruses family which causes" exact="infection" post="in humans; SARS-CoV, MERS-CoV, and SARS-CoV-2 can cause acute"/>
 <result pre="MERS-CoV outbreak in September 2012, caused 2494 confirmed cases of" exact="infection" post="and 858 mortalities, including 38 fatalities in South Korea"/>
 <result pre="GMT. At present, available data shows that 2019-nCoV spread the" exact="infection" post="to the human population from a bat source, but"/>
 <result pre="herbal medicine plays a major role in the prevention and" exact="treatment" post="of many diseases also for the novel coronavirus. Chinese"/>
 <result pre="Chloroquine was proved to be effective in the control and" exact="treatment" post="of SARS-CoV2 [34]. There was wide usage of traditional"/>
 <result pre="Herein, we will mention various drugs used for viral disease" exact="treatment" post="which is also showing inhibitory effect, etc. in COVID-19"/>
 <result pre="COVID-19 infection. Favipiravir Favipiravir is a drug approved for the" exact="treatment" post="of influenza in China. The action mechanism of Favipiravir"/>
 <result pre="pH higher than what is required for virus/cell fusion, the" exact="infection" post="is blocked. This interferes with glycoproteins of cellular receptors"/>
 <result pre="Vero E6 cells infected by SARS-CoV-2 at a multiplicity of" exact="infection" post="(MOI) of 0.05, Chloroquine was highly effective in decreasing"/>
 <result pre="effective in decreasing viral replication and it can block SARS-CoV-2" exact="infection" post="at low concentration (half-maximal effective concentration (EC50) of 1.13â€‰Î¼M"/>
 <result pre="and no noticeable side effects were observed. Finally, 13â€‰days after" exact="treatment" post="with Remdesivir the result of real-time RT-PCR analysis from"/>
 <result pre="[66]. The role of the Renin-Angiotensin-Aldosterone System (RAAS) in COVID-19" exact="infection" post="is a hot topic of discussion. RAAS inhibitors, such"/>
 <result pre="and Angiotensin II receptor blockers (ARBs), which are used to" exact="treatment" post="of cardiovascular diseases, have been resulted in increased cell"/>
 <result pre="non-ICU patients and the addition of methylprednisolone to the above" exact="treatment" post="for ICU patients resulted in 26 patients being discharged"/>
 <result pre="interferon (IFN-I) responses is the key characterizing factor for the" exact="diagnosis" post="of the COVID-19 infection stage in humans. The relationship"/>
 <result pre="the key characterizing factor for the diagnosis of the COVID-19" exact="infection" post="stage in humans. The relationship between viral load/IFN levels"/>
 <result pre="relationship between viral load/IFN levels and disease severity in COVID-19" exact="infection" post="marked the key difference in the pathogenesis of this"/>
 <result pre="inhibitors used in combination as a second-line drug for the" exact="treatment" post="of HIV-1 infection in children and grown-ups through the"/>
 <result pre="combination as a second-line drug for the treatment of HIV-1" exact="infection" post="in children and grown-ups through the fewer side effects."/>
 <result pre="the combination of these agents has potential efficacy for the" exact="treatment" post="of patients with MERS-CoV [74â€&quot;76]. The question of whether"/>
 <result pre="of sampling using in the current trial. In brief, lopinavir-ritonavir" exact="treatment" post="did not significantly improve clinical development or reduce-throat viral"/>
 <result pre="its inhibitory effect on IL-6, may be effective in the" exact="treatment" post="of COVID-19 [71]. Vitamin D Vitamin D has many"/>
 <result pre="D has many mechanisms that reduce the risk of microbial" exact="infection" post="and death. Vitamin D with enhance cellular innate immunity"/>
 <result pre="and nonenveloped viruses, and fungi. It is known that COVID-19" exact="infection" post="is associated with the increasing production of pro-inflammatory cytokines,"/>
 <result pre="evidence for that vitamin D can prevent or treat COVID-19" exact="infection" post="and should be further studied before it is recommended"/>
 <result pre="coronavirus replication, zinc is currently being investigated for prophylaxis and" exact="treatment" post="of patients with COVID-19 [84â€&quot;86]. Drug Interactions Although using"/>
 <result pre="patients in cases whose state deteriorated, the last resort in" exact="treatment" post="was applying immunoglobulins or convalescent plasma despite therapy with"/>
 <result pre="from Ebola virus-infected cases who had recovered as an empirical" exact="treatment" post="through prevalence [92]. In 2015, a protocol for the"/>
 <result pre="virus-infected cases who had recovered as an empirical treatment through" exact="prevalence" post="[92]. In 2015, a protocol for the use of"/>
 <result pre="of the results for indicating the efficacy of convalescent plasma" exact="treatment" post="is that the antibodies from these kinds of plasma"/>
 <result pre="the effects of this antibody were not only blocking new" exact="infection" post="and viral clearance but also involves fast clearance of"/>
 <result pre="immunoglobulin, and steroids [99]. WHO recommended the main focus on" exact="infection" post="prevention, infected detection and monitoring, and supportive treatment for"/>
 <result pre="[99]. WHO recommended the main focus on infection prevention, infected" exact="detection" post="and monitoring, and supportive treatment for COVID-19. However, there"/>
 <result pre="focus on infection prevention, infected detection and monitoring, and supportive" exact="treatment" post="for COVID-19. However, there is not any special anti-SARS-CoV-2"/>
 <result pre="treatment for COVID-19. However, there is not any special anti-SARS-CoV-2" exact="treatment" post="recommended due to the lack of evidence. There is"/>
 <result pre="claimed that 10 severely ill patients receiving this convalescent plasma" exact="treatment" post="showed better oxygenation and less inflammation and viral load"/>
 <result pre="of plasma were 5 patients who were recovered from SARS-CoV-2" exact="infection" post="and they were the ages of 18 and 60â€‰years"/>
 <result pre="Patient 2 was receiving ECMO at the time of plasma" exact="treatment" post="but did not require ECMO on day 5 after"/>
 <result pre="mechanical ventilation Discharged home Discharged home Discharged home The plasma" exact="treatment" post="project as a complementary therapy method initiated on 26"/>
 <result pre="in plasma from recovering COVID-19-infected cases can help stop the" exact="infection" post="in people who are still sick or not. Dr."/>
 <result pre="Secretary Matt Hancock donates to the trial of COVID-19 plasma" exact="treatment" post="in the UK [105]. COVID-19 needs quick development of"/>
 <result pre="the UK [105]. COVID-19 needs quick development of successful medicinal" exact="treatment" post="modalities. Convalescent plasma may be one of them. However,"/>
 <result pre="a vaccine at the preclinical phase, which is enduring animal" exact="testing" post="and is estimated to be ready for human trials"/>
 <result pre="(https://www.businessinsider.com/india-serum-institute-millions-oxford-university-vaccine-before-approval-2020-4). And finally, Vir Biotechnology is using whole-genome CRISPR based" exact="screening" post="to produce Anti-coronavirus monoclonal antibodies [113]. There are more"/>
 <result pre="were effective for other SARS-CoV, may be helpful for this" exact="infection" post="too. Results of covalent plasma and under development vaccines"/>
 <result pre="camostat mesylate which is a nonspecific protease inhibitor can inhibit" exact="infection" post="and disease with a Pseudovirus bearing the S protein"/>
 <result pre="to clarify the effect of hrsACE2 at later stages of" exact="infection" post="in vitro and in vivo. Finally the Best Way"/>
 <result pre="has covid-19 and so it is more difficult to maintain" exact="social distancing." post=". Avoid touching eyes, nose, and mouth because you"/>
 <result pre="Therefore, for keeping away from COVID-19, the best way is" exact="social distancing" post="and observing the personal hygiene. Moreover, It is a"/>
 <result pre="for virus origins and receptor binding. Lancet. 2020;395(10224):565â€&quot;574.doi: 10.1016/S0140-6736(20)30251-8. 24.PiepenburgOWilliamsCHStempleDLArmesNADNA" exact="detection" post="using recombination proteinsPLoS Biol200647e20416756388 25.[cited 2020 march 27]; Coronavirus"/>
 <result pre="march 28]; Available from: https://www.cdc.gov/features/rhinoviruses/index.html. 31.DavisJMMurphyEAMcClellanJLCarmichaelMDGangemiJDQuercetin reduces susceptibility to influenza" exact="infection" post="following stressful exerciseAm J Physiol Regul Integ Comp Physiol20082952R505R509"/>
 <result pre="to pandemicJ Immuno Allerg20201318 33.JinYHCaiLChengZSChengHDengTFanYPFangCHuangDHuangLQHuangQHanYA rapid advice guideline for the" exact="diagnosis" post="and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia"/>
 <result pre="Immuno Allerg20201318 33.JinYHCaiLChengZSChengHDengTFanYPFangCHuangDHuangLQHuangQHanYA rapid advice guideline for the diagnosis and" exact="treatment" post="of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)Military"/>
 <result pre="Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studies. Bioscience Trends."/>
 <result pre="current evidence. Int J Antimicrob Agents. 2020:105948. 10.1016/j.ijantimicag.2020.105948. 37.ZhangDHWuKLZhangXDengSQPengBIn silico" exact="screening" post="of Chinese herbal medicines with the potential to directly"/>
 <result pre="X, Gu Y, Cai Q, Yang Y, Shen C. Experimental" exact="treatment" post="with favipiravir for COVID-19: an open-label control study. Engineering."/>
 <result pre="2006;6(2):67â€&quot;69.doi: 10.1016/S1473-3099(06)70361-9. 47.VincentMJBergeronEBenjannetSEricksonBRRollinPEKsiazekTGSeidahNGNicholSTChloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol J2005211015631631 48.KwiekJJHaysteadTARudolphJKinetic mechanism of quinone oxidoreductase 2"/>
 <result pre="193â€&quot;198). Springer, Boston, MA.doi: 10.1007/978-1-4615-1325-4_31. 51.KonoMTatsumiKImaiAMSaitoKKuriyamaTShirasawaHInhibition of human coronavirus 229E" exact="infection" post="in human epithelial lung cells (L132) by chloroquine: involvement"/>
 <result pre="and projection of optimized dosing design of hydroxychloroquine for the" exact="treatment" post="of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin"/>
 <result pre="https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19. 57.PedersenNCPerronMBannaschMMontgomeryEMurakamiELiepnieksMLiuHEfficacy and safety of the nucleoside analog GS-441524 for" exact="treatment" post="of cats with naturally occurring feline infectious peritonitisJ Feline"/>
 <result pre="be used for managing symptoms, say doctors and scientists. 79.XuXHanMLiTSunWWangDFuBZhouYZhengXYangYLiXZhangXEffective" exact="treatment" post="of severe COVID-19 patients with tocilizumabProc Natl Acad Sci202011720109701097532350134"/>
 <result pre="VE, Dupont HT, HonorÃ© S. Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trial."/>
 <result pre="10.1016/j.ijantimicag.2020.105949. 89.SooYOChengYWongRHuiDSLeeCKTsangKKNgMHChanPChengGSungJJRetrospective comparison of convalescent plasma with continuing high-dose methylprednisolone" exact="treatment" post="in SARS patientsClin Microbiol Infect200410767667815214887 90.LaiSTTreatment of severe acute"/>
 <result pre="recovered from Ebola virus disease for transfusion, as an empirical" exact="treatment" post="during outbreaks: interim guidance for national health authorities and"/>
 <result pre="syndrome coronavirus infection: a study protocolSpringerplus2015411825674489 94.HungIFcollab: To KKLeeCKLeeKLChanKYanWWLiuRWattCLChanWMLaiKYKooCKConvalescent plasma" exact="treatment" post="reduced mortality in patients with severe pandemic influenza A"/>
 <result pre="Millar JE, Baillie JK. Clinical evidence does not support corticosteroid" exact="treatment" post="for 2019-nCoV lung injury. Lancet. 2020;395(10223):473â€&quot;475.doi: 10.1016/S0140-6736(20)30317-2. 100.Chen L,"/>
 <result pre="critically ill patients with COVID-19 with convalescent plasmaJAMA.2020323161582158910.1001/jama.2020.4783 103.Iran starts" exact="testing" post="plasma treatment plan for COVID19 patients. 2020; Available from:"/>
 <result pre="patients with COVID-19 with convalescent plasmaJAMA.2020323161582158910.1001/jama.2020.4783 103.Iran starts testing plasma" exact="treatment" post="plan for COVID19 patients. 2020; Available from: https://en.irna.ir/news/83728876/Iran-starts-testing-plasma-treatment-plan-for-COVID19-patients. 104.The"/>
</results>
